Filamentary keratitis

Summary

Filamentary keratitis (MONDO:0003082) is a disease and 2 clinical trials. A subtype of keratitis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 2

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	filamentary keratitis
Mondo ID	MONDO:0003082
DOID	DOID:4664
ICD-10-CM	H16.12
ICD-11	942510664
SNOMED CT	51286002
UMLS	C0155077
MedGen	509773
Is cancer (heuristic)	no

Disease family

This is a subtype of keratitis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › disorder of orbital region › eye disorder › corneal disorder › keratitis › filamentary keratitis

Related subtypes (10): macular keratitis, superficial keratitis, photokeratitis, scleroperikeratitis, corneal ulcer, keratoconjunctivitis, deep keratitis, corneal neovascularization, autosomal dominant keratitis, corneal infection

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 2.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	2

Top trials by phase / activity

NCT	Phase	Status	Title
NCT02859246	Not specified	COMPLETED	Mucinex® for Treatment of Filamentary Keratitis
NCT05891106	Not specified	COMPLETED	AONDA Therapeutic Indication Study I